Zydus Cadila's COVID Vaccine Offers Immunity in Phase 1/2 Trials
4 years ago

Zydus Cadila's COVID Vaccine Offers Immunity in Phase 1/2 Trials

The Quint  

The trial has been reviewed by an independent Data Safety Monitoring Board and reports have been submitted to Central Drugs Standard Control Organisation regularly for the update on safety outcome. Pankaj R. Patel, Chairman of the Zydus Group said, "After establishing safety in phase I clinical trial, ZyCoV-D has now completed Phase II clinical trials and the vaccine has been found to be safe and immunogenic. We are optimistic of phase III clinical trial outcomes as well and that we would be able to start production of the novel vaccine on its successful completion." The platform is also known to show much improved vaccine stability thus requiring lower cold chain requirements. The plasmid DNA when introduced into the host cells would be translated into the viral protein and will elicit a strong immune response mediated by the cellular and humoral arms of the human immune system, which play a vital role in protection from disease as well as viral clearance.

Vaccine  zydus  offers  phase  immunity  12  platform  trial  vaccine  cadilas  covid  zycovd  safety  viral  trials  clinical  requirements

History of this topic

India clears 2 vaccines for kids under 12 years
2 years, 7 months ago

India clears 2 vaccines for kids under 12 years

Hindustan Times  

India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Currently, Bharat Biotech’s Covaxin, an inactivated …

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts
2 years, 10 months ago

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts

News 18  

Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab
3 years ago

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab

News 18  

After the first indigenous Covid-19 vaccine, Covaxin, India is all set to roll out its second made-in-India vaccine. It is a needle-free vaccine administered in three doses, tested at Central Drug Laboratory at Kasauli in Himachal Pradesh and manufactured by Cadila Healthcare. The official further said the company’s vaccine is based on “plug and play technology” as it can be …

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing
3 years ago

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing

News 18  

Seven batches comprising 2,37,530 doses of India’s first DNA vaccine ZyCoV-D to fight Covid, manufactured by Cadila Healthcare, have been released after being tested by the Central Drug Laboratory in Kasauli. In addition to that, 466 batches of Covaxin, 549 of Covishield, seven of Janssen and 24 batches of Sputnik V have also been released, Dr Arun Bhardwaj, director, CDL, …

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose
3 years, 1 month ago

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose

News 18  

The central government has placed an order of one crore doses of Zydus Cadila’s ZyCoV-D, the world’s first plasmid DNA vaccine, at Rs 265 per dose, the company said in a statement on Monday. The needle-free applicator will cost Rs 93 per dose, excluding GST, the company said, adding that the pricing has been decided in consultation with the Centre. …

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine
3 years, 1 month ago

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine

Live Mint  

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. "The Centre has already placed a purchase order with Zydus Cadila for supply of one crore doses of ZyCoV-D, each costing …

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources
3 years, 1 month ago

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources

News 18  

Zydus Cadila has agreed to bring down the price of its Covid-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing Rs 93 is required for each dose, which would take the …

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report
3 years, 1 month ago

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report

Live Mint  

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to ₹265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing ₹93 is required for each dose, which would take the price to …

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report
3 years, 2 months ago

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report

News 18  

A day after Bharat Biotech’s Covaxin was approved for emergency use for children in the 2 to 18 age group, there’s more good news. A total of 60 lakh doses of Zydus Cadila’s ZyCoV-D vaccine are ready after production, according to top government sources quoted in a report by news agency Asian News International. According to the ANI report, in …

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals
3 years, 2 months ago

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals

News 18  

The first vaccine approved for use among children in the age group of 12-17 in India namely ZyCoV-D, will also be made available to private sector hospitals across the country as per reports. “If there are buyers, up to 25 lakh doses of the ZyCoV-D would be made available to private sector hospitals every month as the initial monthly vaccine …

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On
3 years, 2 months ago

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On

News 18  

With the national rollout of Zydus Cadila’s Covid vaccine, ZyCoV-D just 2 weeks away, different batches of ZyCoV-D are undergoing a final round of quality checks at the vaccine testing laboratory in Himachal Pradesh. Talking to TOI, NK Arora, chairman of the Centre’s Covid working group of the National Technical Advisory Group on Immunisation expressed that if everything works out …

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price
3 years, 2 months ago

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price

News 18  

Around 1.5 lakh doses of Zydus Cadila’s ZyCoV-D vaccine have cleared the quality test at Central Drugs Laboratory, in Kasauli, Himachal Pradesh, sources told CNN-News18, adding that the government is currently in negotiation with the manufacturers to bring down the commercial price of the jab. It has taken longer for the government and manufacturers to negotiate the price of the …

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive
3 years, 2 months ago

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive

News 18  

Zydus Cadila?s Covid-19 DNA vaccine will be?introduced? On August 20, DCGI approved Zydus Cadila vaccine for emergency use in adults and children aged 12 years and above. LIVE Updates At the weekly health ministry briefing, Health Secretary Rajesh Bhushan said:?Zydus vaccine will be introduced very soon. Last week, responding to a question at a press conference, NITI Aayog Member Dr …

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry
3 years, 2 months ago

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry

India Today  

The health ministry has said that Zydus Cadila's Covid-19 vaccine would be introduced in the national vaccination programme very shortly. Union health secretary Rajesh Bhushan said, “Zydus Cadila vaccine has been given approval. We are in conversation with the manufacturers about the pricing of the vaccine.” “Since it is a 3-dose vaccine, it would have differential pricing than the currently …

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
3 years, 2 months ago

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

Firstpost  

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi The Central government, along with pharmaceutical company Zydus Cadila is likely to take a call on the pricing of ZyCov-D, the world’s first DNA vaccine to fight COVID-19, with the launch likely on 2 …

PM Modi’s Pitch for Home-Grown Covid Vaccines at UNGA, Invites Jab Manufacturers to India
3 years, 3 months ago

PM Modi’s Pitch for Home-Grown Covid Vaccines at UNGA, Invites Jab Manufacturers to India

News 18  

Prime Minister Narendra Modi on Saturday made a strong pitch for the home-grown coronavirus vaccines, including the world’s first plasmid DNA and nasal vaccines. Addressing the UNGA in New York, PM Modi said, “India has already developed a DNA vaccine that can be administered to people aged 12 year and above. The prime minister also asked vaccine manufacturers to come …

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month
3 years, 3 months ago

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month

News 18  

New Delhi: The Narendra Modi government at the Centre is planning to roll out Zydus Cadila’s Covid-19 vaccine, ZyCoVD, by the end of October, News18 has learnt. The government is expecting the delivery of one crore doses of DNA vaccine which can also be administered to adolescents aged between 12 and 17. In the coming months, India may also add …

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources
3 years, 3 months ago

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

India TV News  

Zydus Cadila's needle-free coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources. Indigenously developed Zydus Cadila's ZyCoV-D had received approval for Emergency Use Authorisation from the drug regulator two weeks ago, making it the first vaccine in the country which would be administered in the age group of 12-18 years. On the kind of negotiations …

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD
3 years, 3 months ago

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD

News 18  

Price of India’s second home-grown Covid-19 vaccine, ZyCoV-D, will be decided basis the technology, capacity and volume, and it will be “affordable”, Dr Sharvil Patel, managing director of Zydus Group, the company manufacturing the vaccine, told News18.com. “Throughout the pandemic, Zydus has provided affordable therapeutics, diagnostics and preventives and ZyCoV-D will be no different.” ZyCoV-D — which is the world’s …

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins
3 years, 3 months ago

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins

News 18  

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research here. Indigenously developed Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the …

ZyCoV-D vaccine safe and effective for adolescents, says expert
3 years, 3 months ago

ZyCoV-D vaccine safe and effective for adolescents, says expert

The Hindu  

Arora, a senior member of National COVID-19 Task Force and Advisor, national AEFI committee, speaks to The Hindu about the ZyCoV-D vaccine — the world’s first plasmid DNA vaccine for human use — and how it could be the beginning of a vaccine revolution. ZyCoV-D vaccine is the world’s first plasmid DNA vaccine for human use. Any new vaccine is …

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan
3 years, 4 months ago

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan

News 18  

The National Technical Advisory Group on Immunisation will hold a key meet this week to outline the roadmap for the introduction of DNA-based Zydus Cadila’s vaccine in the general population. It is expected that the meet will help prepare a plan on how to inculcate and introduce the Zycov-D vaccine in India’s immunisation programme. The official added that adolescents with …

Zydus Cadila to start making 1 crore doses of Covid vaccine by October
3 years, 4 months ago

Zydus Cadila to start making 1 crore doses of Covid vaccine by October

India Today  

Zydus Cadila announced on Saturday that they will start producing one crore doses of Covid-19 vaccine by October. When asked about the government projection that there would be five crore doses of Zydus Cadila vaccine in August, Dr Sharvil Patel, Managing Director of Zydus Cadila, said, “We faced a delay of 45 days to commission the new plant,” and added, …

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid
3 years, 4 months ago

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid

News 18  

Indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D on Friday received Emergency Use Authorisation from the Drug Controller General of India. Johnson & Johnson Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said. Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. The SII is …

Zycov-D, India’s first COVID-19 vaccine for those above 12, gets nod
3 years, 4 months ago

Zycov-D, India’s first COVID-19 vaccine for those above 12, gets nod

The Hindu  

The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group, on Friday, making it the first vaccine in India that can be administered to adults as well as those 12 and above. This vaccine had already exhibited robust immunogenicity and tolerability and safety profile in the adaptive Phase …

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above
3 years, 4 months ago

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above

News 18  

Indian drug regulator DCGI on Friday approved Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorized for use in the country. After news of the approval, Prime Minister Narendra Modi and Union Health Minister Mansukh Mandaviya lauded India’s fight against Covid-19, with another weapon in …

ZyCoV-D, World's 1st DNA Plasmid Covid-19 Vaccine Gets Approval: All About India's 2nd Homegrown Jab
3 years, 4 months ago

ZyCoV-D, World's 1st DNA Plasmid Covid-19 Vaccine Gets Approval: All About India's 2nd Homegrown Jab

News 18  

ZyCoV-D, a three-dose Covid-19 vaccine by Ahmedabad-based pharmaceutical firm Cadila Healthcare, was on Friday received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 years and above. Zydus Cadila had earlier said that they can launch their three-dose plasmid DNA Covid-19 vaccine within two months of receiving the approval. …

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod
3 years, 4 months ago

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod

News 18  

The Indian drug regulator?s subject expert committee has recommended emergency use approval for Zydus Cadila?s three-dose COVID-19 vaccine. The generic drugmaker, listed as Cadila Healthcare Ltd, applied for the authorisation of the vaccine ZyCoV-D on July 1, based on an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. Zydus Cadila had earlier said that …

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya
3 years, 4 months ago

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya

Firstpost  

AIIMS Director Dr Randeep Guleria recently said data of phase two and three trials of Bharat Biotech’s Covaxin on 2 to 18 years age group is expected by September Ahmedabad: Union Health Minister Mansukh Mandaviya on Thursday said results of ongoing research for the development of COVID-19 vaccines for children may arrive next month and the antidote may be launched …

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds

India Today  

Vaccine maker Zydus Cadila's three-dose Covid vaccine ZyCoV-D has got DCGI approval for emergency use authorisation. The Subject Expert Committee of Central Drugs Standard Control Organisation had recommended an emergency use authorization for Zydus Cadila's three-dose Covid-19 vaccine, ZyCoV-D. ZyCoV-D is a three-dose, intradermal vaccine, which is applied using a needle-free system, Tropis, which can also lead to a significant …

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report
3 years, 4 months ago

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report

India TV News  

Zydus Cadila Vaccine News: The Government is likely to give its nod for emergency use authorisation to Zydus Cadila's needle-free Covid-19 vaccine 'ZyCoV-D' this week, news agency ANI reported on Monday. 'ZyCoV-D' will be a three-dose vaccine and the companys plans to manufacture 10-12 crore doses annually, Zydus Cadila had said in a statement last month. Last week, Union Health …

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds

India Today  

The Covid vaccine candidate of Zydus Cadila is likely to get emergency use authorisation from the Centre this week, sources told India Today. The company has conducted the largest clinical trial for its Covid-19 vaccine in India, including on the adolescent population in the 12-18 years age group. If approved, ZyCoV-D would be the first vaccine in India for the …

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works
3 years, 5 months ago

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works

Firstpost  

These vaccines work by inserting a piece of the virus’s genetic information into the body to prompt cells to produce a key component of the virus which the immune system then recognises and attacks by producing antibodies Union Health Minister Mansukh Mandaviya told Parliament that India is set to become the first country in the world to roll out a …

EXPLAINED: 'India To Have World's First DNA Vaccine', Here's How The ZyCoV-D Shot Works
3 years, 5 months ago

EXPLAINED: 'India To Have World's First DNA Vaccine', Here's How The ZyCoV-D Shot Works

News 18  

Union Health Minister Mansukh Mandaviya told Parliament that India is set to become the first country in the world to roll out a DNA vaccine against the novel coronavirus. Earlier this month, Zydus Cadila said it had sought emergency use authorisation from the Drug Controller General of India for the world’s first plasmid DNA vaccine after preliminary results from Phase-III …

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources
3 years, 5 months ago

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources

News 18  

The Gujarat-based pharma company Zydus Cadila is expected to provide additional data related to immunogenicity and safety of its vaccinate candidate ZyCoV-D to the Drugs Controller General of India this week, according to sources. Zydus’ three-dose vaccine was reported to be 66.6 per cent effective against symptomatic Covid cases and 100 per cent effective for moderate infection. NITI Aayog member …

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court
3 years, 5 months ago

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court

Live Mint  

Indian drugmaker Zydus Cadila's Covid-19 vaccine may be available for children in the 12 to 18 age group soon, the central government has told Delhi High Court. "Zydus Cadila has concluded its trial for children between the age group of 12 to 18 and is subject to statutory permissions," the Centre said in an affidavit submitted on Friday. Further, the …

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC
3 years, 5 months ago

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC

India Today  

The Centre informed the Delhi High Court that Zydus Cadila has concluded the clinical trial of its DNA-based Covid-19 vaccine ZyCoV-D for the 12-18 age group and that it could soon be available. In an affidavit dated July 15, Satyendra Singh, Under Secretary to the Ministry of Health and Family Welfare, said, "It is submitted that Zydus Cadila which is …

DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt
3 years, 5 months ago

DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt

News 18  

The recommendations of the Drugs Controller General of India on Zydus Cadila’s ZyCoV-D three-dose vaccine are likely to be out soon, NITI Aayog member VK Paul said on Friday. Zydus has said the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in …

Decision on Zydus needle-free Covid vaccine in few days. What you need to know
3 years, 5 months ago

Decision on Zydus needle-free Covid vaccine in few days. What you need to know

Live Mint  

Ahmadabad-based drugmaker Zydus Cadila's application for the emergency use authorization of its Covid-19 vaccine will likely be taken up by a Subject Expert Committee of India's drug regulator this week, reported news agency Reuters, citing an Economic Times report. The company had last week submitted an application to the Drugs Controller General of India, seeking authorisation for its ZyCoV-D three-dose …

ZyCoV-D: Decoding the Science behind India’s Plasmid DNA Vaccine & What Makes it Special
3 years, 5 months ago

ZyCoV-D: Decoding the Science behind India’s Plasmid DNA Vaccine & What Makes it Special

News 18  

A year ago, the term ‘plasmid’ may have generated little interest among people. But on July 1, 2021, this changed, even if momentarily, when Ahmedabad-based Zydus Cadila announced that it had applied for emergency use authorisation of its COVID-19 vaccine, ZyCoV-D, which is set to become the world’s first plasmid DNA vaccine for human use. DNA vaccines involve direct injection …

Can Launch Vaccine Within 2 Months If Approved, Says Zydus Cadila on World's 1st Plasmid DNA Shot
3 years, 5 months ago

Can Launch Vaccine Within 2 Months If Approved, Says Zydus Cadila on World's 1st Plasmid DNA Shot

News 18  

Ahmedabad-based pharmaceutical firm Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the world’s first Plasmid DNA vaccine. According to Dr Sharvil Patel, Managing Director, Cadila Healthcare, the vaccine has shown primary efficacy of 66.6 per cent for symptomatic RT-PCR positive cases. “The Vaccine has shown primary efficacy of 66.6 per cent for symptomatic …

As Zydus Cadila Seeks Nod for World’s Ist Plasmid DNA Shot, Here’s Everything About its Science
3 years, 5 months ago

As Zydus Cadila Seeks Nod for World’s Ist Plasmid DNA Shot, Here’s Everything About its Science

News 18  

Ahmedabad-based pharmaceutical firm Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the world’s first Plasmid DNA vaccine. Zydus claims its vaccine is 66.6 per cent effective against symptomatic Covid cases and 100 per cent for moderate disease. Purified plasmid DNA containing an antigen’s coding sequences and the necessary regulatory elements to express them …

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India
3 years, 5 months ago

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

India TV News  

Zydus Cadila has applied for Emergency Use Authorisation nod from the Drugs Controller General of India for the launch of its DNA vaccine, ZyCoV-D, for 12 years and above. If DGCA grants approval, ZyCoV-D will join Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russia's Sputnik V vaccines to be authorized for emergency use in India. The company said …

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds
3 years, 5 months ago

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds

Live Mint  

Zydus Cadila today announced that the company has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19. This was also the first time that any COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India. As the first ever plasmid …

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end
3 years, 5 months ago

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end

India Today  

The 'needle-free' Zydus Cadila vaccine will come with an applicator, which the company has developed with PharmaJet. A study done with the DNA vaccine between April and June showed a 66% efficacy rate in symptomatic cases, said Sharvil Patel, managing director, Zydus Cadila, There were no cases of death even in moderate to severe cases after the third dose of …

Zydus Cadila seeks emergency use nod for its 'needle-free', three-dose vaccine
3 years, 5 months ago

Zydus Cadila seeks emergency use nod for its 'needle-free', three-dose vaccine

India Today  

Zydus Cadila on Thursday announced that the company has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA Vaccine against Covid-19. This was also the first time that any Covid-19 vaccine has been tested in adolescent population in the 12-18 years age group in India. Whereas, no moderate case …

Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19
3 years, 5 months ago

Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19

India Today  

Zydus Cadila on Thursday applied for emergency use authorisation for its Covid-19 vaccine. The company has approached the Drug Controller General of India for a nod to its ZyCoV-D — Plasmid DNA vaccine. As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against COVID-19. ZyCoV-D is a plasmid DNA …

Clinical trials over, Zydus Cadila vaccine for 12-18 age group soon: Centre informs Supreme Court
3 years, 5 months ago

Clinical trials over, Zydus Cadila vaccine for 12-18 age group soon: Centre informs Supreme Court

India Today  

The Centre on Saturday informed the Supreme Court that Zydus Cadila, which is developing DNA vaccine, has concluded its clinical trials for the 12 to 18 age group, and the vaccine may be available in near future, subject to the statutory permissions. Moreover, the Centre told the Supreme Court that a total of 51.6 crore Covid vaccine doses would be …

Zydus Cadila may apply for emergency use approval of its Covid vaccine in 7-10 days: Sources
3 years, 6 months ago

Zydus Cadila may apply for emergency use approval of its Covid vaccine in 7-10 days: Sources

India Today  

In a development that could boost India's vaccination drive, Ahmedabad-based vaccine manufacturer Zydus Cadila has told the Centre that it could apply for emergency use authorisation for its Covid-19 vaccine ZyCoV-D in the next seven to ten days, sources privy to the development have told India Today TV. Apart from adults, Zydus Cadila is also conducting trials of its vaccine …

Covid-19: Serum Institute to begin Novavax vaccine trials for children in July
3 years, 6 months ago

Covid-19: Serum Institute to begin Novavax vaccine trials for children in July

India Today  

The Serum Institute of India is expected to begin clinical trials of the Novavax vaccine for children in July of this year. Clinical trials for Covaxin will also be conducted for children in the 6-12 age group followed by the 2-6 age group. Vaccine maker Bharat Biotech is also conducting clinical trials of its nasal Covid-19 vaccine for children. The …

Discover Related